Saslimšana ar nieru vēzi palielinās visā pasaulē. Eiropā tas ir septītais visizplatītākais vēzis , bet trīspadsmitais pasaulē. Šī darba mērķis bija noskaidrot, kur visbiežāk lokalizējas nieru vēža metastāzes un kā mainās sistēmiskas pretvēža terapijas efektivitāte atkarībā no metastāžu lokalizācijas un skarto orgānu skaita. Lai sasniegtu mērķi, tika izvirzīta hipotēze, ka cilvēkam, kuram ir vēža metastāzes plaušās, kopējā vidējā dzīvildze būs lielāka (respektīvi, dzīvos ilgāk) nekā tiem, kuriem metastāzes būs citos orgānos. Pētījumā par nieru vēža (KSS-10, kods C64) metastāzēm tika izmantoti dati sākot no 2006. gada līdz. 2014. gadam. Dati tika ievākti VSIA „Paula Stradiņa Klīniskās universitātes slimnīcas”, Onkoloģijas klīnikā un tās arhīv...
Renal cell carcinoma accounts for 3% of all adult malignant tumors. Common sites of metastases are l...
The management of metastatic renal cell carcinoma had changed over the last ten years with the appar...
Cilj istraživanja: Ispitati učestalost pušenja, pretilosti i hipertenzije kod pacijenata s karcinomo...
Saslimstība ar ļaundabīgajiem nieru audzējiem palielinās katru gadu, visizteiktāk tas vērojams pasau...
Nieru šūnu karcinoma sastāda 80-85% [Michael B atkins et al, 2016] no visām nieru malignitātēm, nesk...
Objectives: Aim of this study was to figure out whether localization and amount of lung metastases c...
Renal cell carcinoma is the third leading urologic cancer. Thirty percent of patients with renal cel...
Renal Hücreli Karsinom (RHK) tüm kanserlerin %2-3'lük kısmını oluşturmaktadır. En yüksek insidans, g...
Targeted therapy with sunitinib as first treatment option for metastatic renal carcinoma appeared in...
Molekyylimarkkerit ja pitkäaikainen alfainterferonihoito munuaissyövässä Munuaissyöpäpotilaiden v...
Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/OpenInng...
Svjetlostanični tip karcinoma bubrežnih stanica najčešći je oblik raka bubrega. Klinički je uglavnom...
Renal cancer represents approximately 3 % of total malignancies. Based on the statistics distant met...
Tıpta Uzmanlık TeziAkciğer kanseri tanı ve tedavi alanındaki tüm gelişmelere rağmen tüm dünyada her ...
Napredak u razumijevanju i poznavanju molekularnih puteva rasta i razvoja tumora bubrega doveo je do...
Renal cell carcinoma accounts for 3% of all adult malignant tumors. Common sites of metastases are l...
The management of metastatic renal cell carcinoma had changed over the last ten years with the appar...
Cilj istraživanja: Ispitati učestalost pušenja, pretilosti i hipertenzije kod pacijenata s karcinomo...
Saslimstība ar ļaundabīgajiem nieru audzējiem palielinās katru gadu, visizteiktāk tas vērojams pasau...
Nieru šūnu karcinoma sastāda 80-85% [Michael B atkins et al, 2016] no visām nieru malignitātēm, nesk...
Objectives: Aim of this study was to figure out whether localization and amount of lung metastases c...
Renal cell carcinoma is the third leading urologic cancer. Thirty percent of patients with renal cel...
Renal Hücreli Karsinom (RHK) tüm kanserlerin %2-3'lük kısmını oluşturmaktadır. En yüksek insidans, g...
Targeted therapy with sunitinib as first treatment option for metastatic renal carcinoma appeared in...
Molekyylimarkkerit ja pitkäaikainen alfainterferonihoito munuaissyövässä Munuaissyöpäpotilaiden v...
Neðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/OpenInng...
Svjetlostanični tip karcinoma bubrežnih stanica najčešći je oblik raka bubrega. Klinički je uglavnom...
Renal cancer represents approximately 3 % of total malignancies. Based on the statistics distant met...
Tıpta Uzmanlık TeziAkciğer kanseri tanı ve tedavi alanındaki tüm gelişmelere rağmen tüm dünyada her ...
Napredak u razumijevanju i poznavanju molekularnih puteva rasta i razvoja tumora bubrega doveo je do...
Renal cell carcinoma accounts for 3% of all adult malignant tumors. Common sites of metastases are l...
The management of metastatic renal cell carcinoma had changed over the last ten years with the appar...
Cilj istraživanja: Ispitati učestalost pušenja, pretilosti i hipertenzije kod pacijenata s karcinomo...